clinical trial · NCT05143307
Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101
Excision BioTherapeutics·phase1·enrolling by invitation·n = 9
HIV-1-infectionEBT-101
brief summary
Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).
started
Jul 11, 2023
primary completion
Jan 1, 2037
completion
Apr 1, 2037
last updated
May 14, 2024
detailed description
Participants who receive EBT-101 in a parent protocol will be eligible to participate in this LTFU study (EBT-101-002). All participants will have follow-up visits every six months until Year 5 post EBT-101. Thereafter, all participants will have follow-up visits annually on the anniversary of EBT-101 administration until study completion at Year 15.
official title
Long-Term Follow-Up Study of HIV-1 Infected Adults Exiting a Parent Study Where EBT-101 Was Administered
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol